MCID: ADL019
MIFTS: 39

Adult Fibrosarcoma

Categories: Cancer diseases, Rare diseases, Bone diseases

Aliases & Classifications for Adult Fibrosarcoma

MalaCards integrated aliases for Adult Fibrosarcoma:

Name: Adult Fibrosarcoma 12 15 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3516
NCIt 50 C7809
UMLS 73 C0278595

Summaries for Adult Fibrosarcoma

MalaCards based summary : Adult Fibrosarcoma is related to adult mesoblastic nephroma and pediatric fibrosarcoma. An important gene associated with Adult Fibrosarcoma is NTRK3 (Neurotrophic Receptor Tyrosine Kinase 3), and among its related pathways/superpathways are HTLV-I infection and Vemurafenib Pathway, Pharmacodynamics. The drugs Doxorubicin and Mechlorethamine have been mentioned in the context of this disorder. Affiliated tissues include bone, lung and bone marrow, and related phenotypes are growth/size/body region and cardiovascular system

Related Diseases for Adult Fibrosarcoma

Diseases in the Fibrosarcoma family:

Adult Fibrosarcoma Congenital Fibrosarcoma

Diseases related to Adult Fibrosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 58)
# Related Disease Score Top Affiliating Genes
1 adult mesoblastic nephroma 10.7 ETV6 NTRK3
2 pediatric fibrosarcoma 10.7 ETV6 NTRK3
3 cellular congenital mesoblastic nephroma 10.7 ETV6 NTRK3
4 congenital fibrosarcoma 10.7 ETV6 NTRK3
5 ring chromosome 4 10.6 COL1A1 PDGFB
6 botryoid rhabdomyosarcoma 10.6 MB MYOD1
7 bednar tumor 10.6 COL1A1 PDGFB
8 breast secretory carcinoma 10.6 ETV6 NTRK3
9 mesenchymoma 10.6 MB MYOD1
10 spindle cell rhabdomyosarcoma 10.6 MB MYOD1
11 dermis tumor 10.5 COL1A1 PDGFB
12 pleomorphic rhabdomyosarcoma 10.5 MB MYOD1
13 myofibroma 10.5 ETV6 MB
14 acinar cell carcinoma 10.5 ETV6 NTRK3
15 mixed liposarcoma 10.5 MB PDGFB
16 kidney rhabdoid cancer 10.4 MB WT1
17 skin sarcoma 10.4 COL1A1 PDGFB
18 rhabdoid cancer 10.4 MYOD1 WT1
19 osteogenesis imperfecta, type v 10.3 COL1A1 FDPS
20 bone ewing's sarcoma 10.3 PDGFB WT1
21 connective tissue cancer 10.3 COL1A1 NTRK3 PDGFB
22 malignant fibrous histiocytoma of bone 10.3 HRAS MYOD1
23 congenital mesoblastic nephroma 10.2 ETV6 NTRK3 WT1
24 melanomatosis 10.1 HRAS WT1
25 uterine sarcoma 10.1 MB WT1
26 mixed cell type cancer 10.1 HRAS MB
27 gallbladder sarcoma 10.1 MYOD1 MYOG
28 undifferentiated embryonal sarcoma of the liver 10.1 MYOD1 MYOG
29 inflammatory leiomyosarcoma 10.1 MYOD1 MYOG
30 conventional leiomyosarcoma 10.1 MYOD1 MYOG
31 hereditary wilms' tumor 10.1 HRAS WT1
32 pseudosarcomatous fibromatosis 10.0 MYOG NTRK3
33 orbit rhabdomyosarcoma 10.0 MB MYOG
34 differentiated thyroid carcinoma 10.0 ETV6 HRAS NTRK3
35 fibrosarcoma 10.0
36 embryonal sarcoma 10.0 MYOD1 MYOG
37 core binding factor acute myeloid leukemia 10.0 HRAS WT1
38 skin benign neoplasm 9.9 COL1A1 HRAS
39 extraosseous ewing's sarcoma 9.7 MYOD1 MYOG
40 leukemia, chronic myeloid 9.7 ETV6 HRAS WT1
41 breast rhabdomyosarcoma 9.7 MB MYOD1 MYOG
42 ovarian cancer 1 9.7 HRAS WT1
43 medullomyoblastoma 9.7 MB MYOD1 MYOG
44 skeletal muscle cancer 9.6 MB MYOD1 MYOG
45 dermatofibrosarcoma protuberans 9.6
46 spindle cell liposarcoma 9.6 MYOD1 MYOG WT1
47 nephrogenic adenofibroma 9.6 MYOD1 MYOG WT1
48 malignant ovarian surface epithelial-stromal neoplasm 9.5 HRAS WT1
49 hematologic cancer 9.5 ETV6 HRAS WT1
50 rhabdomyosarcoma 9.5 MB MYOD1 MYOG

Graphical network of the top 20 diseases related to Adult Fibrosarcoma:



Diseases related to Adult Fibrosarcoma

Symptoms & Phenotypes for Adult Fibrosarcoma

MGI Mouse Phenotypes related to Adult Fibrosarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.09 PDGFB WT1 MYOG HRAS NTRK3 MB
2 cardiovascular system MP:0005385 10.08 WT1 PDGFB HRAS NTRK3 MB COL1A1
3 mortality/aging MP:0010768 10.02 PDGFB WT1 ETV6 MYOG HRAS NTRK3
4 homeostasis/metabolism MP:0005376 10.01 PDGFB WT1 ETV6 MYOG HRAS MB
5 embryo MP:0005380 9.93 PDGFB WT1 ETV6 MYOG MB COL1A1
6 muscle MP:0005369 9.8 PDGFB WT1 MYOG MB COL1A1 MYOD1
7 no phenotypic analysis MP:0003012 9.76 WT1 PDGFB MYOG HRAS NTRK3 COL1A1
8 neoplasm MP:0002006 9.65 WT1 ETV6 HRAS COL1A1 MYOD1
9 normal MP:0002873 9.5 WT1 MYOG HRAS NTRK3 COL1A1 MYOD1
10 respiratory system MP:0005388 9.23 WT1 PDGFB MYOG HRAS NTRK3 MB

Drugs & Therapeutics for Adult Fibrosarcoma

Drugs for Adult Fibrosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 120)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 23214-92-8 31703
2
Mechlorethamine Approved, Investigational Phase 3,Phase 2,Phase 1,Not Applicable 51-75-2 4033
3
Ifosfamide Approved Phase 3,Phase 2,Phase 1,Not Applicable 3778-73-2 3690
4
Lenograstim Approved, Investigational Phase 3,Phase 2 135968-09-1
5
Etoposide Approved Phase 3,Phase 2 33419-42-0 36462
6
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
7
Vincristine Approved, Investigational Phase 3,Phase 2 2068-78-2, 57-22-7 5978
8
Cyclophosphamide Approved, Investigational Phase 3,Phase 2 50-18-0, 6055-19-2 2907
9
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 2019 457193
10
Epirubicin Approved Phase 3,Phase 2 56420-45-2 41867
11
Trabectedin Approved, Investigational Phase 2, Phase 3 114899-77-3 108150
12
Cyproheptadine Approved Phase 3 129-03-3 2913
13
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
14
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1,Not Applicable 31703
15
Isophosphamide mustard Phase 3,Phase 2,Phase 1,Not Applicable 0
16 Alkylating Agents Phase 3,Phase 2,Phase 1,Not Applicable
17 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
18 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
19 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
20 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1,Not Applicable
21 Imatinib Mesylate Phase 2, Phase 3,Phase 1 220127-57-1 123596
22 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2
23 Etoposide phosphate Phase 3,Phase 2
24 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
25 Anti-Infective Agents Phase 3,Phase 2,Phase 1
26 Protein Kinase Inhibitors Phase 2, Phase 3,Phase 1
27 Antirheumatic Agents Phase 3,Phase 2,Phase 1
28 Antimitotic Agents Phase 3,Phase 1,Phase 2
29 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
30
Histamine Phosphate Phase 3 51-74-1 65513
31 Serotonin Agents Phase 3
32 Serotonin Antagonists Phase 3
33 Gastrointestinal Agents Phase 3
34 Neurotransmitter Agents Phase 3
35 Histamine Antagonists Phase 3
36 Histamine H1 Antagonists Phase 3
37 Dermatologic Agents Phase 3
38 Anti-Allergic Agents Phase 3
39 Antipruritics Phase 3
40
Serotonin Investigational, Nutraceutical Phase 3 50-67-9 5202
41
Dacarbazine Approved, Investigational Phase 2 4342-03-4 5351166
42
Temozolomide Approved, Investigational Phase 2 85622-93-1 5394
43
Sorafenib Approved, Investigational Phase 2 284461-73-0 216239 406563
44
Vinblastine Approved Phase 1, Phase 2 865-21-4 13342 241903
45
Topotecan Approved, Investigational Phase 2 119413-54-6, 123948-87-8 60700
46
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
47
Thiotepa Approved, Investigational Phase 2 52-24-4 5453
48
Sunitinib Approved, Investigational Phase 2 341031-54-7, 557795-19-4 5329102
49
Everolimus Approved Phase 2,Phase 1 159351-69-6 6442177
50
Paclitaxel Approved, Vet_approved Phase 1, Phase 2,Phase 2 33069-62-4 36314

Interventional clinical trials:

(show top 50) (show all 92)
# Name Status NCT ID Phase Drugs
1 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma Unknown status NCT00334854 Phase 3 doxorubicin hydrochloride;ifosfamide
2 Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00346164 Phase 3 doxorubicin hydrochloride;ifosfamide
3 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
4 Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00003212 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
6 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00002641 Phase 3 doxorubicin hydrochloride;ifosfamide;isolated perfusion
7 Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00061984 Phase 3 doxorubicin hydrochloride;ifosfamide
8 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis Completed NCT00091351 Phase 3
9 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma Completed NCT00002898 Phase 3 carboplatin;cyclophosphamide;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
10 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Recruiting NCT02180867 Phase 2, Phase 3 Doxorubicin Hydrochloride;Ifosfamide;Pazopanib Hydrochloride
11 Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma Recruiting NCT01344018 Phase 3
12 Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma Active, not recruiting NCT00423618 Phase 3
13 Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Terminated NCT01189253 Phase 2, Phase 3 doxorubicin hydrochloride;trabectedin
14 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3 cyproheptadine hydrochloride
15 Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors Terminated NCT00427583 Phase 2, Phase 3 imatinib mesylate
16 Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma Unknown status NCT00003718 Phase 2 temozolomide
17 Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma Unknown status NCT00410462 Phase 2 brostallicin;doxorubicin hydrochloride
18 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Completed NCT00400569 Phase 2 Sunitinib Malate (SU011248)
19 Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans Completed NCT00084630 Phase 2 imatinib mesylate
20 Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers Completed NCT00141765 Phase 2
21 BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer Completed NCT00326495 Phase 2 Cetuximab;BAY 43-9006
22 Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma Completed NCT00085475 Phase 2 imatinib mesylate
23 AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00659360 Phase 2 saracatinib
24 Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01154452 Phase 1, Phase 2 Gamma-Secretase Inhibitor RO4929097;Vismodegib
25 Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Completed NCT00112463 Phase 2 romidepsin
26 Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung Completed NCT00503295 Phase 2
27 Bevacizumab and Radiation Therapy for Sarcomas Completed NCT00356031 Phase 2 Bevacizumab
28 Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Completed NCT01614795 Phase 2 Temsirolimus
29 Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00003939 Phase 2 trabectedin
30 STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma Completed NCT00006357 Phase 1, Phase 2 imatinib mesylate
31 Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00041249 Phase 2 brostallicin
32 Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma Completed NCT00041236 Phase 2 exatecan mesylate
33 Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma Completed NCT00053794 Phase 2 perifosine
34 BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors Completed NCT00526149 Phase 2 BI 2536
35 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Completed NCT00474994 Phase 2 sunitinib malate
36 Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma Completed NCT00064220 Phase 2 soblidotin
37 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
38 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00004105 Phase 1, Phase 2 estramustine phosphate sodium;paclitaxel;vinorelbine ditartrate
39 Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone Sarcoma Completed NCT00031915 Phase 2 imatinib mesylate
40 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors Completed NCT00025441 Phase 2 carboplatin;cyclophosphamide;doxorubicin hydrochloride;epirubicin hydrochloride;etoposide;ifosfamide;vincristine sulfate
41 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Completed NCT00002515 Phase 2 carboplatin;thiotepa;topotecan hydrochloride
42 Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans Completed NCT00243191 Phase 2 imatinib mesylate
43 Imatinib in Dermatofibrosarcoma Protuberans (DFSP) Completed NCT00122473 Phase 1, Phase 2 Imatinib (Glivec)
44 Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Completed NCT01653028 Phase 2 Alisertib
45 Sorafenib and Dacarbazine in Soft Tissue Sarcoma Completed NCT00837148 Phase 2 Sorafenib and Dacarbazine
46 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors Completed NCT00304083 Phase 2 doxorubicin hydrochloride;etoposide;ifosfamide
47 Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma Completed NCT00245102 Phase 2 sorafenib tosylate
48 Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes Completed NCT00171912 Phase 2 imatinib mesylate
49 S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Completed NCT00068367 Phase 2 erlotinib hydrochloride
50 Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers Recruiting NCT03215511 Phase 1, Phase 2 LOXO-195

Search NIH Clinical Center for Adult Fibrosarcoma

Genetic Tests for Adult Fibrosarcoma

Anatomical Context for Adult Fibrosarcoma

MalaCards organs/tissues related to Adult Fibrosarcoma:

41
Bone, Lung, Bone Marrow, Testis, Liver

Publications for Adult Fibrosarcoma

Articles related to Adult Fibrosarcoma:

# Title Authors Year
1
CT and MRI Findings of Soft Tissue Adult Fibrosarcoma in Extremities. ( 29693010 )
2018
2
Adult fibrosarcoma: surgical management in developing countries. ( 25528208 )
2015
3
Adult fibrosarcoma of the wrist: a case report. ( 22689150 )
2012
4
Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. ( 11921284 )
2002
5
Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. ( 11329146 )
2001

Variations for Adult Fibrosarcoma

Expression for Adult Fibrosarcoma

Search GEO for disease gene expression data for Adult Fibrosarcoma.

Pathways for Adult Fibrosarcoma

Pathways related to Adult Fibrosarcoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.9 FDPS HRAS PDGFB
2 10.88 HRAS PDGFB
3 10.72 HRAS PDGFB
4
Show member pathways
10.42 FDPS HRAS
5 9.77 COL1A1 PDGFB

GO Terms for Adult Fibrosarcoma

Biological processes related to Adult Fibrosarcoma according to GeneCards Suite gene sharing:

(show all 20)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 9.95 ETV6 HRAS MYOD1 MYOG WT1
2 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.76 HRAS NTRK3 PDGFB
3 positive regulation of transcription, DNA-templated GO:0045893 9.72 COL1A1 MYOD1 MYOG PDGFB WT1
4 positive regulation of MAPK cascade GO:0043410 9.69 HRAS NTRK3 PDGFB
5 cellular response to tumor necrosis factor GO:0071356 9.61 COL1A1 MYOD1 MYOG
6 positive regulation of DNA replication GO:0045740 9.59 HRAS PDGFB
7 cellular response to estradiol stimulus GO:0071392 9.58 MYOD1 MYOG
8 activation of protein kinase B activity GO:0032148 9.57 NTRK3 PDGFB
9 skeletal muscle fiber development GO:0048741 9.56 MYOD1 MYOG
10 positive regulation of muscle cell differentiation GO:0051149 9.54 MYOD1 MYOG
11 positive regulation of myoblast differentiation GO:0045663 9.52 MYOD1 MYOG
12 myoblast differentiation GO:0045445 9.49 MYOD1 MYOG
13 positive regulation of myoblast fusion GO:1901741 9.48 MYOD1 MYOG
14 positive regulation of actin cytoskeleton reorganization GO:2000251 9.46 HRAS NTRK3
15 cellular response to retinoic acid GO:0071300 9.43 COL1A1 MYOG NTRK3
16 myotube differentiation GO:0014902 9.4 MYOD1 MYOG
17 positive regulation of skeletal muscle fiber development GO:0048743 9.37 MYOD1 MYOG
18 heart development GO:0007507 9.26 MB NTRK3 PDGFB WT1
19 muscle cell fate commitment GO:0042693 9.16 MYOD1 MYOG
20 positive regulation of cell migration GO:0030335 8.92 COL1A1 HRAS NTRK3 PDGFB

Molecular functions related to Adult Fibrosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sequence-specific DNA binding GO:0043565 9.56 ETV6 MYOD1 MYOG WT1
2 RNA polymerase II regulatory region sequence-specific DNA binding GO:0000977 9.33 ETV6 MYOD1 MYOG
3 E-box binding GO:0070888 8.96 MYOD1 MYOG
4 platelet-derived growth factor binding GO:0048407 8.62 COL1A1 PDGFB

Sources for Adult Fibrosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....